Abbott trims 2026 profit forecast on Exact deal hit, shares fall
April 16 (Reuters) - Abbott cut its full-year profit forecast on Thursday due to a 20 cent-per-share hit from its recent $23 billion acquisition of cancer test maker Exact Sciences, sending its shares down more than 4% premarket. 
